<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSH</journal-id>
<journal-id journal-id-type="hwp">sprsh</journal-id>
<journal-title>Perspectives in Public Health</journal-title>
<issn pub-type="ppub">1757-9139</issn>
<issn pub-type="epub">1757-9147</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1757913911434497</article-id>
<article-id pub-id-type="publisher-id">10.1177_1757913911434497</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Not all about bones: the non classical role of vitamin D in public health</article-title>
</title-group>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2012</year>
</pub-date>
<volume>132</volume>
<issue>1</issue>
<fpage>6</fpage>
<lpage>6</lpage>
<permissions>
<copyright-statement>© Royal Society for Public Health 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Royal Society for Public Health</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Vitamin D and its therapeutic roles and functions in public health nutrition are well documented; however less information is widespread about its ‘non- classical’ roles.</p>
<p>Vitamin D is a secosteroid derived from dual sources: via the diet or by photolytic cleavage of 7 dehydrocholesterol by ultra violet light in the epidermis.<sup><xref ref-type="bibr" rid="bibr1-1757913911434497">1</xref></sup> The more prodigious and efficient source of the pro hormone is exposure to sunlight.<sup><xref ref-type="bibr" rid="bibr2-1757913911434497">2</xref></sup> Nutritional sources include green vegetables (ergocalciferol), animal fat and egg yolk (cholecalciferol).</p>
<p>The genomic action of vitamin D is mediated by the vitamin D nuclear receptor.<sup><xref ref-type="bibr" rid="bibr3-1757913911434497">3</xref></sup> Calcitriol exerts its physiological action by high affinity binding to the vitamin D nuclear receptors. They are not only present in the bone, kidney, skin and intestine (what could be called the ‘classical organs’) but also in the ‘non-classical’ organs including the brain, eyes, pancreas, muscle, heart and the immune cells.</p>
<p>This recognition of the ‘non classical’ (non calcium homeostasis) role therefore links vitamin D to cardiovascular disease, tuberculosis, diabetes mellitus and susceptibility to sepsis.<sup><xref ref-type="bibr" rid="bibr4-1757913911434497">4</xref>,<xref ref-type="bibr" rid="bibr5-1757913911434497">5</xref></sup> Vitamin D supplementation is being increasingly suggested as an adjuvant in prevention and therapy for these disorders.<sup><xref ref-type="bibr" rid="bibr6-1757913911434497">6</xref></sup></p>
<p>Vitamin D is postulated to play roles in the modulation of adaptive and innate immunity.<sup><xref ref-type="bibr" rid="bibr3-1757913911434497">3</xref></sup> Vitamin D nuclear receptors are abundant in immune cells<sup><xref ref-type="bibr" rid="bibr1-1757913911434497">1</xref></sup> and vitamin D enhances the microbicidal activity of macrophages and monocytes. This is achieved by being pro differentiating and enhancing macrophage chemotaxis and phagocytosis.<sup><xref ref-type="bibr" rid="bibr7-1757913911434497">7</xref>,<xref ref-type="bibr" rid="bibr8-1757913911434497">8</xref></sup> The latter achieves increased microbicidal activity against intracellular bacteria.<sup><xref ref-type="bibr" rid="bibr9-1757913911434497">9</xref></sup></p>
<p>Whilst vitamin D as treatment for Tuberculosis (TB) appears interesting, there is little published evidence to support routine VDS in the general TB populace. Furthermore, no randomised controlled trials (RCT) support vitamin D nuclear receptors in the management of HIV infection at this stage. Although a Cochrane review<sup><xref ref-type="bibr" rid="bibr10-1757913911434497">10</xref></sup> looking at adult and paediatric micronutrient supplementation in HIV evidences one RCT in Africa that reduced morbidity, the one that used only vitamin D nuclear receptors did not show any clinical benefits. Vitamin D has several disease modifying actions in cardiovascular disease<sup><xref ref-type="bibr" rid="bibr11-1757913911434497">11</xref>,<xref ref-type="bibr" rid="bibr12-1757913911434497">12</xref>,<xref ref-type="bibr" rid="bibr13-1757913911434497">13</xref></sup> but no large scale trials support supplementation.</p>
<p>On the other hand vitamin D’s possible role in auto immune disorders is widely reported.<sup><xref ref-type="bibr" rid="bibr14-1757913911434497">14</xref></sup> However, such studies are often small and use differing doses. It is pertinent to consider that the larger doses required to achieve these non classical benefits may cause toxicity unless newer vitamin D analogues are used.</p>
<p>Vitamin D is now recognised as having a broader role in human physiology than just calcium homeostasis. The role of vitamin D in bone homeostasis is evidenced and the World Health Organization in addition to national medical bodies have recommendations in place for its supplementation. In this capacity, there is some evidence to support its role in high risk populations including breast fed infants and others who by reason of attire, latitudes or skin colouring are unable to harness solar synthesis. Yet the search for information to lamppost other roles is hurdled by lack of large RCTs, differing recommendations of adequate levels and fears of toxicity in human trials. Evolutionary arguments, mechanistic data and epidemiological data support its role in infection and auto immune disorders. A resolution may be possible if large scale placebo controlled RCTs are conducted across latitudes and seasons. This may present data to support or refute current practices.</p>
<p>Dr John Philip, M.B.B.S.,D.C.H.,M.Sc,MRSPH</p>
<p>Paediatric Clinical Research Fellow, Oxford Vaccine Group, CVVTM, University of Oxford, <email>drjohnphilip@gmail.com</email></p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-1757913911434497">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baeke</surname><given-names>F</given-names></name>
<name><surname>Takiishi</surname><given-names>T</given-names></name>
<name><surname>Korf</surname><given-names>H</given-names></name>
<name><surname>Gysemans</surname><given-names>C.</given-names></name>
</person-group> <article-title>Mathieu C. Vitamin D: Modulator of the immune system</article-title>, <source>Pharmacology</source> <year>2010</year>, <volume>10</volume> :<fpage>482</fpage>-<lpage>496</lpage></citation>
</ref>
<ref id="bibr2-1757913911434497">
<label>2.</label>
<citation citation-type="book">
<collab>WHO</collab>, <source>Vitamin and mineral requirements in human nutrition: report of a joint FAO/WHO expert consultation</source>, <publisher-name>Bangkok</publisher-name>, <publisher-loc>Thailand</publisher-loc>, <fpage>21</fpage>–<lpage>30</lpage> <month>September</month> <year>1998</year> (<comment>revised 2004</comment>)</citation>
</ref>
<ref id="bibr3-1757913911434497">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Borges</surname><given-names>M C</given-names></name>
<name><surname>Martini</surname><given-names>L</given-names></name>
<name><surname>Rogero</surname><given-names>M</given-names></name>
</person-group>, <article-title>Current perspectives on vitamin D, immune system, and chronic diseases</article-title>, <source>Nutrition</source>, <year>2011</year>, <volume>27</volume>(<issue>4</issue>): <fpage>399</fpage>-<lpage>404</lpage></citation>
</ref>
<ref id="bibr4-1757913911434497">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>L</given-names></name>
<name><surname>Manson</surname><given-names>J E</given-names></name>
<name><surname>Song</surname><given-names>Y</given-names></name>
<name><surname>Sesso</surname><given-names>H D</given-names></name>
</person-group>, <article-title>Systematic Review: Vitamin D and Calcium Supplementation in Prevention of Cardiovascular Events</article-title>, <source>Annals Internal Medicine</source>, <year>2010</year> <volume>152</volume>:<fpage>315</fpage>-<lpage>323</lpage></citation>
</ref>
<ref id="bibr5-1757913911434497">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grant</surname><given-names>W</given-names></name>
</person-group>, <article-title>Solar Ultraviolet-B irradiance and vitamin D may reduce the risk of septicaemia</article-title>, <source>Dermato Endocrinology</source>, <year>2009</year>, <volume>1</volume>(<issue>1</issue>): <fpage>37</fpage>-<lpage>42</lpage></citation>
</ref>
<ref id="bibr6-1757913911434497">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zittermann</surname><given-names>A</given-names></name>
</person-group>, <article-title>Vitamin D in preventive medicine: are we ignoring the evidence?</article-title> <source>British Journal of Nutrition</source>, <year>2003</year>, <volume>89</volume>:<fpage>552</fpage>–<lpage>572</lpage></citation>
</ref>
<ref id="bibr7-1757913911434497">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Griffin</surname><given-names>M</given-names></name>
<name><surname>Xing</surname><given-names>N</given-names></name>
<name><surname>Kumar</surname><given-names>R</given-names></name>
</person-group>, <article-title>Vitamin D and its analogs as regulators of immune activation and antigen presentation</article-title>, <source>Annu Rev Nutr</source>, <year>2003</year>, <volume>23</volume>:<fpage>117</fpage>–<lpage>45</lpage></citation>
</ref>
<ref id="bibr8-1757913911434497">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Griffin</surname><given-names>M</given-names></name>
</person-group>, <article-title>Dong X, Kumar R, Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: A paradigm for ligand-augmented negative transcriptional regulation</article-title>, <source>Archives of Biochemistry and Biophysics</source>, <year>2007</year>, <volume>460</volume>:<fpage>218</fpage>–<lpage>226</lpage></citation>
</ref>
<ref id="bibr9-1757913911434497">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>P.T</given-names></name>
<name><surname>Stenger</surname><given-names>S</given-names></name>
<name><surname>Li</surname><given-names>H</given-names></name>
<name><surname>Wenzel</surname><given-names>L</given-names></name>
<name><surname>Tan</surname><given-names>B.H</given-names></name>
<name><surname>Krutzik</surname><given-names>S.R</given-names></name>
<etal/>
</person-group>, <article-title>Antimicrobial Response Toll-Like Receptor Triggering of a Vitamin D-Mediated Human</article-title>, <source>Science</source>, <year>2006</year>, <volume>311</volume>(<issue>5768</issue>): <fpage>1770</fpage>-<lpage>1773</lpage></citation>
</ref>
<ref id="bibr10-1757913911434497">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Adorini</surname><given-names>L</given-names></name>
<name><surname>Penna</surname><given-names>G</given-names></name>
</person-group>, <article-title>Control of autoimmune diseases by the vitamin D endocrine system</article-title>. <source>Nat Clin Pract Rheumatol</source>, <year>2008</year>, <volume>4</volume>(<issue>8</issue>): <fpage>404</fpage>-<lpage>12</lpage></citation>
</ref>
<ref id="bibr11-1757913911434497">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zittermann</surname><given-names>A</given-names></name>
</person-group>, <article-title>Vitamin D and disease prevention with special reference to cardiovascular disease</article-title>, <source>Progress in Biophysics and Molecular Biology</source>, <year>2006</year>, <volume>92</volume>(<issue>1</issue>):<fpage>39</fpage>-<lpage>48</lpage></citation>
</ref>
<ref id="bibr12-1757913911434497">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>TJ</given-names></name>
<name><surname>Pencina</surname><given-names>MJ</given-names></name>
<name><surname>Booth</surname><given-names>SL</given-names></name>
<name><surname>Jacques</surname><given-names>PF</given-names></name>
<name><surname>Ingelsson</surname><given-names>E</given-names></name>
<name><surname>Lanier</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Vitamin D deficiency and risk of cardiovascular disease</article-title>. <source>Circulation</source>, <year>2008</year>. <volume>117</volume>:<fpage>503</fpage>-<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr13-1757913911434497">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hsia</surname><given-names>J</given-names></name>
<name><surname>Heiss</surname><given-names>G</given-names></name>
<name><surname>Ren</surname><given-names>H</given-names></name>
<name><surname>Allison</surname><given-names>M</given-names></name>
<name><surname>Dolan</surname><given-names>NC</given-names></name>
<name><surname>Greenland</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>Women’s Health Initiative</article-title>. <source>Calcium/vitamin D supplementation and cardiovascular events, Circulation</source>, <year>2007</year>, <volume>115</volume>:<fpage>846</fpage>-<lpage>54</lpage></citation>
</ref>
<ref id="bibr14-1757913911434497">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Adorini</surname><given-names>L</given-names></name>
<name><surname>Penna</surname><given-names>G</given-names></name>
</person-group>, <article-title>Control of autoimmune diseases by the vitamin D endocrine system</article-title>, <source>Nat Clin Pract Rheumatol</source>, <year>2008</year>, <volume>4</volume>(<issue>8</issue>): <fpage>404</fpage>-<lpage>12</lpage></citation>
</ref>
</ref-list>
</back>
<sub-article article-type="other" id="sub1-1757913911434497">
<front-stub>
<title-group>
<article-title>Editor’s response</article-title>
</title-group>
</front-stub>
<body>
<p>We thank Dr John Philip for this interesting letter about the non classical roles of vitamin D. This letter once again draws attention to the importance of vitamin D and opens up further discussion about how vitamin D could have an important role to play in the prevention of such disorders as diabetes and cardiovascular disease.</p>
</body>
</sub-article>
</article>